These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37184905)

  • 21. A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution.
    Lu K; Cheng MC; Ge X; Berger A; Xu D; Kato GJ; Minniti CP
    Clin J Pain; 2014 Sep; 30(9):825-30. PubMed ID: 24322996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-efficacy and embodiment associated with Alexander Technique lessons or with acupuncture sessions: A longitudinal qualitative sub-study within the ATLAS trial.
    Wenham A; Atkin K; Woodman J; Ballard K; MacPherson H
    Complement Ther Clin Pract; 2018 May; 31():308-314. PubMed ID: 29705473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Needs Assessment of Persons With Sickle Cell Disease in a Major Medical Center in North Carolina.
    Masese RV; Crego N; Douglas C; Rains G; Bonnabeau E; DeMartino T; Shah N; Tanabe P
    N C Med J; 2021; 82(5):312-320. PubMed ID: 34544765
    [No Abstract]   [Full Text] [Related]  

  • 25. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
    Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the Relative Effectiveness of Combining Self-Care with Practitioner-Delivered Complementary and Integrative Health Therapies to Improve Pain in a Pragmatic Trial.
    Zeliadt SB; Coggeshall S; Gelman H; Shin MH; Elwy AR; Bokhour BG; Taylor SL
    Pain Med; 2020 Dec; 21(Suppl 2):S100-S109. PubMed ID: 33313736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using the consolidated framework for implementation research to identify recruitment barriers and targeted strategies for a shared decision-making randomized clinical trial in pediatric sickle cell disease.
    Strong H; Hood AM; Johnson Y; Hackworth R; Reed-Shackelford M; Ramaswamy R; Varughese T; Quinn CT; Crosby LE
    Clin Trials; 2023 Jun; 20(3):211-222. PubMed ID: 36794731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation.
    Byrnes C; Botello-Harbaum M; Clemons T; Bailey L; Valdes KM; Coleman-Cowger VH
    J Natl Med Assoc; 2022 Apr; 114(2):211-217. PubMed ID: 35093266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric patients with sickle cell disease: use of complementary and alternative therapies.
    Sibinga EM; Shindell DL; Casella JF; Duggan AK; Wilson MH
    J Altern Complement Med; 2006 Apr; 12(3):291-8. PubMed ID: 16646728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study.
    Coleman B; Ellis-Caird H; McGowan J; Benjamin MJ
    Br J Health Psychol; 2016 Feb; 21(1):190-203. PubMed ID: 26333530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition for Adolescents and Young Adults With Sickle Cell Disease in a US Midwest Urban Center: A Multilevel Perspective on Barriers, Facilitators, and Future Directions.
    Calhoun C; Luo L; Baumann AA; Bauer A; Shen E; McKay V; Hooley C; James A; King AA
    J Pediatr Hematol Oncol; 2022 Jul; 44(5):e872-e880. PubMed ID: 35731941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease.
    Baumann AA; Hankins JS; Hsu LL; Gibson RW; Richardson LD; Treadwell M; Glassberg JA; Bourne S; Luo L; Masese RV; Demartino T; Nocek J; Taaffe E; Gollan S; Ruiz OO; Nwosu C; Qashou N; James AS; Tanabe P; King AA
    BMC Health Serv Res; 2023 Nov; 23(1):1245. PubMed ID: 37953236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.
    Smeltzer MP; Howell KE; Treadwell M; Preiss L; King AA; Glassberg JA; Tanabe P; Badawy SM; DiMartino L; Gibson R; Kanter J; Klesges LM; Hankins JS;
    BMJ Open; 2021 Nov; 11(11):e050880. PubMed ID: 34789492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "It's Better in a Group Anyway": Patient Experiences of Group and Individual Acupuncture.
    Chuang E; Hashai N; Buonora M; Gabison J; Kligler B; McKee MD
    J Altern Complement Med; 2018 Apr; 24(4):336-342. PubMed ID: 29446994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study.
    Phillips S; Schlenz AM; D'Alton S; Johnson M; Kanter J
    J Pain; 2023 Jul; 24(7):1240-1250. PubMed ID: 36863679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic pain management in sickle cell disease: A systematic scoping review of controlled trials.
    Sidhom D; Aboul-Hassan D; Clauw DJ; Cofield C; Bergmans R
    Crit Rev Oncol Hematol; 2023 Oct; 190():104087. PubMed ID: 37541536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Quality Brief of an Oncological Multisite Massage and Acupuncture Therapy Program to Improve Cancer-Related Outcomes.
    Fink J; Burns J; Perez Moreno AC; Kram JJF; Armstrong M; Chopp S; Maul SJ; Conway N
    J Altern Complement Med; 2020 Sep; 26(9):820-824. PubMed ID: 32924553
    [No Abstract]   [Full Text] [Related]  

  • 39. Whole Systems Within Whole Systems: The Oregon Health Plan's Expansion of Services for Back and Neck Pain.
    Eaves ER; Hsu CW; DeBar LL; Livingston CJ; Ocker LE; McDonald SJ; Dillon-Sumner L; Ritenbaugh C
    J Altern Complement Med; 2019 Mar; 25(S1):S61-S68. PubMed ID: 30870022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping Evidence-Based Non-Opioid and Non-Pharmacological Pain Management Modalities Across Minnesota: The Non-Opioid Pain Alleviation Information Network Project.
    Prasad A; Printon R; Vang M; Kurschner S; Dusek JA
    J Integr Complement Med; 2024 Jul; 30(7):645-653. PubMed ID: 38108635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.